Literature DB >> 2884238

Lithium-neuroleptic neurotoxicity is dose dependent.

F Miller, J Menninger.   

Abstract

Lithium-neuroleptic combination treatment was studied retrospectively. Six of 22 manic patients who were administered the combination developed neurotoxicity. The dosage of neuroleptic administered, and not the serum lithium level or lithium dose, predicted which patients became neurotoxic.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2884238

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


  6 in total

Review 1.  Differential pharmacokinetics of lithium in elderly patients.

Authors:  B A Sproule; B G Hardy; K I Shulman
Journal:  Drugs Aging       Date:  2000-03       Impact factor: 3.923

Review 2.  Clinically significant interactions of psychotropic agents with antipsychotic drugs.

Authors:  M C Meyer; R J Baldessarini; D C Goff; F Centorrino
Journal:  Drug Saf       Date:  1996-11       Impact factor: 5.606

3.  Reversible lithium neurotoxicity: review of the literatur.

Authors:  Ivan Netto; Vivek H Phutane
Journal:  Prim Care Companion CNS Disord       Date:  2012

Review 4.  Clinical relevance of drug interactions with lithium.

Authors:  P R Finley; M D Warner; C A Peabody
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

5.  Neurotoxicity related to lithium and neuroleptic combinations? A retrospective review.

Authors:  J B Kessel; C Verghese; G M Simpson
Journal:  J Psychiatry Neurosci       Date:  1992-03       Impact factor: 6.186

6.  Treatment of the special patient with schizophrenia.

Authors:  R R Conley; D L Kelly
Journal:  Dialogues Clin Neurosci       Date:  2001-06       Impact factor: 5.986
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.